Results 11 to 20 of about 729,530 (145)

Development and clinical feasibility testing of the Pain Treatment Planning Questionnaire

The Journal of Haemophilia Practice, 2020
Chronic pain is common in people with bleeding disorders and can complicate clinical management, impair quality of life, and contribute to disability. People living with bleeding disorders often seek advice on pain management from the bleeding disorder ...
Tupper Susan M, Nilson JoAnn, King Jennifer, Downe Pamela, Hodgson Nancy, Schlosser Tara, Brose Kelsey   +6 more
doaj   +1 more source

The thrombotic spectrum of B-thalassemia

Thrombosis Update, 2022
B-thalassemia is one of the most common recessive monogenic disorders, characterized by phenotypic diversity, lifelong treatment and severe complications. Apart from anemia, extramedullary erythropoiesis with skeletal deformities, iron overload and organ
Mavra Vasilopoulou, Christos Stafylidis, Marianna Politou   +2 more
doaj   +1 more source

Incorporating the patient voice and patient engagement in GOAL‐Hēm: Advancing patient‐centric hemophilia care

Research and Practice in Thrombosis and Haemostasis, 2022
Background Goal Attainment Scaling for Hemophilia (GOAL‐Hēm) is a novel, hemophilia‐specific, validated patient engagement tool and patient‐reported outcome instrument.
Jonathan C. Roberts, Michael Recht, Sarah E. Gonzales, Justin Stanley, Michael Denne, Jorge Caicedo, Kenneth Rockwood   +6 more
doaj   +1 more source

Endometrial bleeding [PDF]

Human Reproduction Update, 2007
Abnormal bleeding is a significant health problem, especially during adolescence and before menopause when anovulatory cycles are common. Curettage is rarely necessary to investigate or treat menstrual problems in adolescents, and its use should also be minimized in women younger than 40 years.
D. Apter, D. T. Baird, J. Collins, H. O. D. Critchley, A. L. H. Evers, A. Glasier, P.P. Vercellini, K. Vogelson, G. Benagiano, P.G. Crosignani, E. Diczfalus   +10 more
openaire   +2 more sources

From Vision to Action: National Bleeding Disorders Foundation’s Roadmap for Achieving Health Equity, Diversity, and Inclusion

Health Equity
Background: The National Bleeding Disorders Foundation (NBDF) consistently hears from lived experience experts about daily challenges preventing them from leading their best life and thriving physically, mentally, and emotionally.
Keri L. Norris, Marissa Melton, Karina Lopez, Dawn Rotellini, Leonard A. Valentino   +4 more
doaj   +1 more source

The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States

Platelets, 2020
Immune thrombocytopenia (ITP) is the most common bleeding disorder diagnosed in children. Characterized by low platelet counts, it leads to reduced clotting abilities and an increased tendency to bleed.
Jaime Shaw, Karynsa Kilpatrick, Melissa Eisen, Michael Tarantino   +3 more
doaj   +1 more source

Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes

Bleeding, Thrombosis and Vascular Biology
We report three unrelated cases of Hermansky-Pudlak (HP) characterized by novel mutations in HPS3 (compound heterozygosity for c.1457G>A and c.1813G>T), HPS6 (homozygous c.210_211insGGGCC), and HPS8 (homozygous c.299dupC in BLOC1S3) genes.
Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman   +4 more
doaj   +1 more source

A message of science, peace and gratitude

Bleeding, Thrombosis and Vascular Biology
As we approach Christmas and the New Year 2026 - which will be the fifth for our journal - we want to extend our heartfelt gratitude to our Section Editors, to every eminent Colleague of the Editorial Board, to the Authors, reviewers, readers of the ...
Giovanni de Gaetano, Chiara Cerletti
doaj   +1 more source

A Pharmacist-Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization among Patients with Sickle Cell Disease

Advances in Hematology
Sickle cell disease (SCD) is a common genetic disorder with potentially serious sequelae that can be effectively treated with hydroxyurea. Despite its favorable benefit-risk profile, hydroxyurea uptake in patients with SCD is low.
Cameron Roessner, Trudy Sale, Kelsey Uminski, Dawn Goodyear, Natalia Rydz   +4 more
doaj   +1 more source

At the age of three

Bleeding, Thrombosis and Vascular Biology
At the age of three, a little boy is able to undress and is starting to dress independently, can eat using a spoon and fork, knows how to hold a pencil correctly, and enjoys drawing vertical, horizontal, and curved lines with pencils and colored crayons.
Giovanni de Gaetano, Chiara Cerletti
doaj   +1 more source